Cytokinetics, Incorporated (CYTK)

Cytokinetics Stock Forecast

Stock Price Forecast

According to 22 analysts polled by S&P Global, Cytokinetics stock has a consensus rating of "Buy" and an average price target of $104.7. The average 1-year stock price forecast is 37.24% higher than the current stock price, while the lowest is $69 (-9.56%) and the highest is $146 (+91.38%).

Price Target: $104.7 (+37.24%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$69	$104.7	$104	$146
Change	-9.56%	+37.24%	+36.32%	+91.38%

Analyst Ratings

The average analyst rating for Cytokinetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	10	10	10	10	11	12
Buy	7	7	7	7	7	7
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	20	20	20	20	21	22

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Citi No rating	Citi	Buy Initiates $99	Buy	Initiates	$99	+29.77%	May 18, 2026
Maxwell Skor Morgan Stanley	Morgan Stanley	Buy Maintains $103 → $76	Buy	Maintains	$103 → $76	-0.58%	May 18, 2026
Tessa Romero J.P. Morgan	J.P. Morgan	Buy Reiterates $92 → $97	Buy	Reiterates	$92 → $97	+27.15%	May 12, 2026
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Reiterates $140	Buy	Reiterates	$140	+83.51%	May 11, 2026
Yanan Zhu Wells Fargo	Wells Fargo	Buy Maintains $95 → $105	Buy	Maintains	$95 → $105	+37.63%	May 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

105.01M

Increased by 19.28%

from 88.04M

Revenue Next Year

398.80M

Increased by 279.77%

from 105.01M

EPS This Year

-6.56

from -6.54

EPS Next Year

-4.75

from -6.56

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	70.43M	94.59M	7.53M	18.47M	88.04M	105.01M	398.80M
Revenue Growth	26.15%	34.31%	-92.04%	145.34%	376.56%	19.28%	279.77%
EPS	-2.80	-4.33	-5.45	-5.26	-6.54	-6.56	-4.75
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	23	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	191.5M	571.8M
Avg	105.0M	398.8M
Low	61.7M	308.6M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	117.5%	444.5%
Avg	19.3%	279.8%
Low	-29.9%	193.9%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	-5.94	-3.43
Avg	-6.56	-4.75
Low	-7.32	-5.53

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.